Differences in Ocular Findings in Two Siblings: One with Complete and Other with Incomplete Achromatopsia

Overview

Journal Doc Ophthalmol

Specialty Ophthalmology

Date 2017 Feb 16

PMID 28197754

Citations 2

Authors

Shinji Ueno

Ayami Nakanishi

Akira Sayo

Taro Kominami

Yasuki Ito

Takaaki Hayashi

Kazushige Tsunoda

Takeshi Iwata

Hiroko Terasaki

Affiliations

Soon will be listed here.

Abstract

Purpose: Patients with complete achromatopsia (ACHM) lack cone function, and patients with incomplete ACHM have relatively good visual acuity with residual color vision. The pathological mechanism(s) underlying incomplete ACHM has not been determined. The purpose of this study was to determine the pathophysiology of ACHM in two siblings: one with complete ACHM and the other with incomplete ACHM.

Methods: The medical charts of the two siblings were reviewed.

Results: The sibling with incomplete ACHM had decimal visual acuities that ranged from 0.4 to 0.6 and had moderate color blindness in both eyes. Her younger brother was diagnosed with complete ACHM and was not able to hold fixation, had severe pendular nystagmus, visual acuity that ranged from 0.08 to 0.1, and severe color vision abnormalities in both eyes. Optical coherence tomography (OCT) showed that the ellipsoid zone (EZ) was disruptive in the macular region in both patients. However, careful examination of the OCT images in the incomplete ACHM patient showed a high-density EZ in the central fovea. Adaptive optics (AO) fundus imaging of the sibling with incomplete ACHM revealed sparse cone mosaics remaining within 1° of the foveal center with no mosaics visible outside the central fovea. AO fundus imaging could not be performed in Case 2 because of the severe nystagmus.

Conclusion: Our results showed that cone mosaics were present in the central fovea in the sibling with incomplete ACHM patient. This may explain the better visual acuity and color vision in this sibling.

Citing Articles

From Cellular to Metabolic: Advances in Imaging of Inherited Retinal Diseases.

Parameswarappa D, Kulkarni A, Sahoo N, Padhy S, Singh S, Heon E Diagnostics (Basel). 2025; 15(1.

PMID: 39795556 PMC: 11720060. DOI: 10.3390/diagnostics15010028.

A homozygous structural variant of is frequently associated with achromatopsia in Japanese patients with IRD.

Suga A, Mizobuchi K, Inooka T, Yoshitake K, Minematsu N, Tsunoda K Genet Med Open. 2024; 2:101843.

PMID: 39669618 PMC: 11613597. DOI: 10.1016/j.gimo.2024.101843.

Three cases of acute-onset bilateral photophobia.

Ueno S, Inooka D, Meinert M, Ito Y, Tsunoda K, Fujinami K Jpn J Ophthalmol. 2019; 63(2):172-180.

PMID: 30604114 DOI: 10.1007/s10384-018-00649-0.

References

Dubis A, Cooper R, Aboshiha J, Langlo C, Sundaram V, Liu B . Genotype-dependent variability in residual cone structure in achromatopsia: toward developing metrics for assessing cone health. Invest Ophthalmol Vis Sci. 2014; 55(11):7303-11. PMC: 4235328. DOI: 10.1167/iovs.14-14225. View

Smith V, Pokorny J, NEWELL F . Autosomal recessive incomplete achromatopsia with deutan luminosity. Am J Ophthalmol. 1979; 87(3):393-402. DOI: 10.1016/0002-9394(79)90083-7. View

Kohl S, Coppieters F, Meire F, Schaich S, Roosing S, Brennenstuhl C . A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsia. Am J Hum Genet. 2012; 91(3):527-32. PMC: 3511981. DOI: 10.1016/j.ajhg.2012.07.006. View

Chang B, Grau T, Dangel S, Hurd R, Jurklies B, Sener E . A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene. Proc Natl Acad Sci U S A. 2009; 106(46):19581-6. PMC: 2780790. DOI: 10.1073/pnas.0907720106. View

Katagiri S, Yoshitake K, Akahori M, Hayashi T, Furuno M, Nishino J . Whole-exome sequencing identifies a novel ALMS1 mutation (p.Q2051X) in two Japanese brothers with Alström syndrome. Mol Vis. 2013; 19:2393-406. PMC: 3850975. View

Krill A, Deutman A, Fishman M . The cone degenerations. Doc Ophthalmol. 1973; 35(1):1-80. DOI: 10.1007/BF00234530. View

Ueno S, Kawano K, Ito Y, Ra E, Nakanishi A, Nagaya M . NEAR-INFRARED REFLECTANCE IMAGING IN EYES WITH ACUTE ZONAL OCCULT OUTER RETINOPATHY. Retina. 2015; 35(8):1521-30. DOI: 10.1097/IAE.0000000000000502. View

Ueno S, Nakanishi A, Kominami T, Ito Y, Hayashi T, Yoshitake K . In vivo imaging of a cone mosaic in a patient with achromatopsia associated with a GNAT2 variant. Jpn J Ophthalmol. 2016; 61(1):92-98. DOI: 10.1007/s10384-016-0484-7. View

Thiadens A, Somervuo V, van den Born L, Roosing S, van Schooneveld M, Kuijpers R . Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010; 51(11):5952-7. DOI: 10.1167/iovs.10-5680. View

10.

Zhang T, Godara P, Blanco E, Griffin R, Wang X, Curcio C . Variability in Human Cone Topography Assessed by Adaptive Optics Scanning Laser Ophthalmoscopy. Am J Ophthalmol. 2015; 160(2):290-300.e1. PMC: 4506858. DOI: 10.1016/j.ajo.2015.04.034. View

11.

Kohl S, Zobor D, Chiang W, Weisschuh N, Staller J, Menendez I . Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia. Nat Genet. 2015; 47(7):757-65. PMC: 4610820. DOI: 10.1038/ng.3319. View

12.

Carroll J, Dubra A, Gardner J, Mizrahi-Meissonnier L, Cooper R, Dubis A . The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic. Invest Ophthalmol Vis Sci. 2012; 53(13):8006-15. PMC: 3816954. DOI: 10.1167/iovs.12-11087. View

13.

Wissinger B, Gamer D, Jagle H, Giorda R, Marx T, Mayer S . CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet. 2001; 69(4):722-37. PMC: 1226059. DOI: 10.1086/323613. View

14.

Thomas M, Kumar A, Kohl S, Proudlock F, Gottlob I . High-resolution in vivo imaging in achromatopsia. Ophthalmology. 2011; 118(5):882-7. DOI: 10.1016/j.ophtha.2010.08.053. View

15.

Pokorny J, Smith V, Pinckers A, Cozijnsen M . Classification of complete and incomplete autosomal recessive achromatopsia. Graefes Arch Clin Exp Ophthalmol. 1982; 219(3):121-30. DOI: 10.1007/BF02152296. View

16.

Sundaram V, Wilde C, Aboshiha J, Cowing J, Han C, Langlo C . Retinal structure and function in achromatopsia: implications for gene therapy. Ophthalmology. 2013; 121(1):234-245. PMC: 3895408. DOI: 10.1016/j.ophtha.2013.08.017. View

17.

Wang I, Khan N, Branham K, Wissinger B, Kohl S, Heckenlively J . Establishing baseline rod electroretinogram values in achromatopsia and cone dystrophy. Doc Ophthalmol. 2012; 125(3):229-33. DOI: 10.1007/s10633-012-9350-1. View

18.

Hayashi T, Kozaki K, Kitahara K, Kubo A, Nishio Y, Omoto S . Clinical heterogeneity between two Japanese siblings with congenital achromatopsia. Vis Neurosci. 2004; 21(3):413-20. DOI: 10.1017/s0952523804213396. View

19.

Nakanishi A, Ueno S, Kawano K, Ito Y, Kominami T, Yasuda S . Pathologic Changes of Cone Photoreceptors in Eyes With Occult Macular Dystrophy. Invest Ophthalmol Vis Sci. 2015; 56(12):7243-9. DOI: 10.1167/iovs.15-16742. View

20.

Michaelides M, Hunt D, Moore A . The cone dysfunction syndromes. Br J Ophthalmol. 2004; 88(2):291-7. PMC: 1771989. DOI: 10.1136/bjo.2003.027102. View